These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24724757)

  • 1. Case report, aetiology, and treatment of an acquired long-QT syndrome.
    Van Asbroeck PJ; Huybrechts W; De Soir R
    Acta Clin Belg; 2014 Apr; 69(2):132-4. PubMed ID: 24724757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
    Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol unmasks susceptibility to drug-induced long QT syndrome and torsades de pointes.
    Letsas KP; Efremidis M; Sideris A
    Int J Cardiol; 2008 Mar; 124(3):366-7; author reply 368-9. PubMed ID: 17400314
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced QT prolongation: consequences and current dilemma.
    Dubrey SW; Grocott-Mason R
    Br J Hosp Med (Lond); 2007 Jan; 68(1):50-1. PubMed ID: 17260721
    [No Abstract]   [Full Text] [Related]  

  • 7. A heartless brain.
    Chauveau S; Derex L; Chevalier P
    Europace; 2013 Jun; 15(6):848. PubMed ID: 23349457
    [No Abstract]   [Full Text] [Related]  

  • 8. [Conversion to sinus rhythm].
    Brunckhorst CB
    Praxis (Bern 1994); 2006 Feb; 95(7):247-8. PubMed ID: 16524116
    [No Abstract]   [Full Text] [Related]  

  • 9. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.
    de Gregorio C; Morabito G; Cerrito M; Dattilo G; Oreto G
    Int J Cardiol; 2011 Apr; 148(2):226-8. PubMed ID: 19540606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medication associated long QT syndrome].
    Bruggisser M; Rätz Bravo A; Bodmer M
    Praxis (Bern 1994); 2009 Dec; 98(24):1409-15; quiz 1415. PubMed ID: 19953465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QT interval prolongation and Torsades de Pointes in a patient receiving zolpidem and amiodarone.
    Letsas KP; Filippatos GS; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Cardiology; 2006; 105(3):146-7. PubMed ID: 16449812
    [No Abstract]   [Full Text] [Related]  

  • 14. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aliskiren-induced QT interval prolongation.
    Peitz GJ; Malesker MA; Sojka SG
    South Med J; 2009 Apr; 102(4):411-2. PubMed ID: 19279548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studies.
    Shah RR
    Novartis Found Symp; 2005; 266():251-80; discussion 280-5. PubMed ID: 16050273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Citalopram and Torsades de Pointes. A case report].
    Meuleman C; Jourdain P; Bellorini M; Sadeg N; Loiret J; Guillard N; Thebault B; Funck F
    Arch Mal Coeur Vaiss; 2001 Sep; 94(9):1021-4. PubMed ID: 11603066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.